<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is not well established whether there is an association among common inherited gene defects, Factor V (FV) Leiden, the prothrombin (PT) G20210A mutation, C677T <z:chebi fb="13" ids="29357,29358">methylene</z:chebi> <z:chebi fb="0" ids="20506,26907">tetrahydrofolate</z:chebi> reductase (MTHFR) and ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to evaluate the association of these mutations with posterior ocular involvement in 89 BD patients from eastern Spain (48 men and 41 women) of whom 23 had posterior ocular involvement and 66 did not </plain></SENT>
<SENT sid="2" pm="."><plain>None of the 23 BD patients with posterior ocular involvement was a carrier of either FV Leiden or the PTG20210A mutation </plain></SENT>
<SENT sid="3" pm="."><plain>Only 1 patient was a carrier of the 677TT MTHFR mutation, whereas 4 patients carried FV Leiden, 3 the PTG20210A mutation and 10 the 677TT MTHFR mutation in the group without posterior ocular involvement (p = 0.227, p = 0.556, p = 0.144), respectively </plain></SENT>
<SENT sid="4" pm="."><plain>In our geographical area, the commonest thrombophilic mutations do not seem to be related with posterior ocular involvement in BD patients </plain></SENT>
</text></document>